Cardiofaciocutaneous syndrome 2
MONDO:0014112Any cardiofaciocutaneous syndrome in which the cause of the disease is a mutation in the KRAS gene.
Also known as: KRAS cardiofaciocutaneous syndrome, cardiofaciocutaneous syndrome 2, cardiofaciocutaneous syndrome caused by mutation in KRAS, cardiofaciocutaneous syndrome caused by mutation in kras, cardiofaciocutaneous syndrome type 2, kras cardiofaciocutaneous syndrome, CFC2
12 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Could a short course of steroids calm a dangerous heart rhythm?
Disease control ENROLLING_BY_INVITATIONThis trial tests whether an 8-week course of the immunosuppressive drug prednisone can reduce episodes of ventricular tachycardia (a potentially fatal fast heart rhythm) and improve heart function in people with non-ischemic cardiomyopathy and confirmed heart inflammation. Partic…
Phase: PHASE4 • Sponsor: Roderick Tung • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Super MRI could spot hidden heart damage
Diagnosis OngoingThis study tests whether a new, more powerful 7 Tesla MRI can better detect scarring and swelling in the heart muscle of people with cardiomyopathy. Researchers will scan 13 adults aged 20-70 to see if the higher-resolution images improve diagnosis. The goal is to see if this adv…
Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC